Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Silverman

Showing results (271-280 of 311) with videos related to

Pageof 32
Sort By:
Ecancermedicalscience|January 26, 2012
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an updateL R Silverman, P Fenaux, G J Mufti, et al.
Autism Research : Official Journal of the International Society for Autism Research|January 15, 2019
How effective is LENA in detecting speech vocalizations and language produced by children and adolescents with ASD in different contexts?Rebecca M Jones, Daniela Plesa Skwerer, Rahul Pawar, et al.
Academic Radiology|June 15, 2014
Residents' performance in the interpretation of on-call "triple-rule-out" CT studies in patients with acute chest painK Gabriel Garrett, Carlo N De Cecco, U Joseph Schoepf, et al.
European Radiology|June 14, 2013
Dual-energy CT lung ventilation/perfusion imaging for diagnosing pulmonary embolismLong Jiang Zhang, Chang Sheng Zhou, U Joseph Schoepf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B studyAlice B Kornblith, James E Herndon, Lewis R Silverman, et al.
Radiology|March 19, 2015
CT Evaluation of Small-Diameter Coronary Artery Stents: Effect of an Integrated Circuit Detector with Iterative ReconstructionLucas L Geyer, G Russell Glenn, Carlo Nicola De Cecco, et al.
Leukemia Research|May 23, 2020
Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 studyShyamala C Navada, Guillermo Garcia-Manero, Rosalie OdchimarReissig, et al.
Leukemia Research|May 26, 2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemiaAnne-Marie O'Farrell, Helene A Yuen, Beverly Smolich, et al.
Blood Cancer Journal|December 15, 2017
Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive careAziz Nazha, Mikkael A Sekeres, Rami Komrokji, et al.
European Journal of Radiology|April 23, 2013
Influence of observer experience and training on proficiency in coronary CT angiography interpretationChristopher Herzog, J Matthias Kerl, Salvatore De Rosa, et al.
Pageof 32

Showing results (271-280 of 311) with videos related to

Sort By:
Pageof 32
Ecancermedicalscience|January 26, 2012
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an updateL R Silverman, P Fenaux, G J Mufti, et al.
Autism Research : Official Journal of the International Society for Autism Research|January 15, 2019
How effective is LENA in detecting speech vocalizations and language produced by children and adolescents with ASD in different contexts?Rebecca M Jones, Daniela Plesa Skwerer, Rahul Pawar, et al.
Academic Radiology|June 15, 2014
Residents' performance in the interpretation of on-call "triple-rule-out" CT studies in patients with acute chest painK Gabriel Garrett, Carlo N De Cecco, U Joseph Schoepf, et al.
European Radiology|June 14, 2013
Dual-energy CT lung ventilation/perfusion imaging for diagnosing pulmonary embolismLong Jiang Zhang, Chang Sheng Zhou, U Joseph Schoepf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B studyAlice B Kornblith, James E Herndon, Lewis R Silverman, et al.
Radiology|March 19, 2015
CT Evaluation of Small-Diameter Coronary Artery Stents: Effect of an Integrated Circuit Detector with Iterative ReconstructionLucas L Geyer, G Russell Glenn, Carlo Nicola De Cecco, et al.
Leukemia Research|May 23, 2020
Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 studyShyamala C Navada, Guillermo Garcia-Manero, Rosalie OdchimarReissig, et al.
Leukemia Research|May 26, 2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemiaAnne-Marie O'Farrell, Helene A Yuen, Beverly Smolich, et al.
Blood Cancer Journal|December 15, 2017
Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive careAziz Nazha, Mikkael A Sekeres, Rami Komrokji, et al.
European Journal of Radiology|April 23, 2013
Influence of observer experience and training on proficiency in coronary CT angiography interpretationChristopher Herzog, J Matthias Kerl, Salvatore De Rosa, et al.
Pageof 32